GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurogene Inc (NAS:NGNE) » Definitions » Sale Of Investment

Neurogene (Neurogene) Sale Of Investment : $30.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Neurogene Sale Of Investment?

Neurogene's sale of investment for the three months ended in Mar. 2024 was $30.00 Mil. It means Neurogene gained $30.00 Mil from selling investments. Neurogene's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was $30.00 Mil.

Compared with last quarter ($0.00 Mil in Dec. 2023 ), Neurogene gained more money from selling investments in Mar. 2024 ($30.00 Mil).


Neurogene Sale Of Investment Historical Data

The historical data trend for Neurogene's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurogene Sale Of Investment Chart

Neurogene Annual Data
Trend Dec21 Dec22 Dec23
Sale Of Investment
- - 5.00

Neurogene Quarterly Data
Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial - - - - 30.00

Neurogene Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $30.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neurogene Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Neurogene's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurogene (Neurogene) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
535 W 24th Street, 5th Floor, New York, NY, USA, 10011
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.

Neurogene (Neurogene) Headlines